Agenus grants director options on 7,500 shares

AGENUS INC (AGEN) reported that director Marco Tullio Marcucci received a grant of 7,500 stock options on August 5, 2026.

Available on EDGAR 09/16/2026 - 02:42 PM EDT Accepted by SEC EDGAR 09/16/2026 - 02:41 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

AGENUS INC (AGEN) reported that director Marco Tullio Marcucci received a grant of 7,500 stock options on August 5, 2026. The options have an exercise price of $7.78 per share, expire on August 5, 2036, and relate to 7,500 shares of common stock. According to the award terms, the options vest in three equal annual installments starting on the first anniversary of the grant date, subject to continued service on the Board of Directors. After this grant, Marcucci holds 7,500 options directly.

Insider Trade Summary

Grant/Award: 7,500 shares

Grant/Award 1 txn

Insider Marcucci Marco Tullio

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	7,500	$0.00	$0.00

Holdings After Transaction: Stock Option — 7,500 contracts (Direct)

Footnotes (1)

1. F1. Option awarded in connection with Mr. Marcucci's appointment to the Board of Directors, vesting in three equal annual installments commencing on the first anniversary of the date of grant, subject to continued service.

Key Figures

Stock options granted: 7,500 options Exercise price: $7.78 per share Underlying shares: 7,500 shares +3 more

6 metrics

Stock options granted 7,500 options Grant to director on August 5, 2026

Exercise price $7.78 per share Exercise price of stock options granted August 5, 2026

Underlying shares 7,500 shares Common stock underlying the granted stock options

Expiration date August 5, 2036 Expiration of the granted stock options

Post-transaction option holdings 7,500 options Director’s direct holdings after the reported grant

Vesting schedule 3 equal annual installments Beginning on first anniversary of August 5, 2026 grant date

Key Terms

Stock Option, vesting, Board of Directors

3 terms

Stock Option financial

"The reporting person received a grant of 7,500 Stock Option awards"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vesting financial

"Option awarded ... vesting in three equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Board of Directors financial

"awarded in connection with Mr. Marcucci's appointment to the Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AGEN (AGENUS INC) report for Marco Tullio Marcucci?

AGEN reported that director Marco Tullio Marcucci received a grant of 7,500 stock options on August 5, 2026, as compensation in connection with his appointment to the Board of Directors.

What is the exercise price and expiration date of the new AGEN stock options?

The granted stock options have an exercise price of $7.78 per share and an expiration date of August 5, 2036, giving the director the right to purchase AGEN common stock at that price until expiration, subject to vesting.

How do the newly granted AGEN stock options vest for the director?

The options vest in three equal annual installments, beginning on the first anniversary of the August 5, 2026 grant date. Vesting is subject to continued service by Marco Tullio Marcucci on the Board of Directors.

How many AGEN stock options does the director hold after this Form 4 transaction?

Following this grant, Marco Tullio Marcucci is reported to hold 7,500 stock options directly. These options are exercisable for 7,500 shares of AGEN common stock, subject to the vesting schedule.

Was the AGEN insider stock option grant made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not checked, and no footnote states otherwise. The reported 7,500 stock option grant therefore is not described as made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marcucci Marco Tullio

(Last) (First) (Middle)

3 FORBES ROAD

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$7.78	08/05/2026		A		7,500		(1)	08/05/2036	Common Stock	7,500	$0.00	7,500	D

Explanation of Responses:

1. Option awarded in connection with Mr. Marcucci's appointment to the Board of Directors, vesting in three equal annual installments commencing on the first anniversary of the date of grant, subject to continued service.

	/s/ Melissa Orilall, as Attorney-in-Fact for Marcucci Marco Tullio	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)